CLINICAL_TRIALS
trial_result
· 2016-11-18
Clinical Trial Update: The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009) [Phase 1]
Summary
A Phase 1 trial assessing how hepatic insufficiency affects the pharmacokinetics of elbasvir (MK-8742).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2016-11-18